Effect of insulin-like growth factor i in murine muscular dystrophy

Martin M. Zdanowicz, Jeffrey Moyse, Mark A. Wingertzahn, Margaret O’connor, Saul Teichberg, Alfred E. Slonim

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


In muscular dystrophy there is an imbalance between muscle protein synthesis and protein degradation, resulting in net muscle catabolism and progressive muscle weakness and wasting. Both insulin and insulin-like growth factor I (IGF-I) are known to have an anabolic effect on skeletal muscle, which is believed to be enhanced in the presence of elevated concentrations of amino acids. We examined the effects of 4-week administration of recombinant human IGF-I (rhIGF-I), both alone and supplemented with a high protein diet (HPD), on muscle metabolism, morphology, and function in the 129 ReJ dystrophic mouse. rhIGF-I significantly reduced muscle protein degradation (P < 0.001), increased muscle protein content (P < 0.05), decreased fiber area variability (P < 0.01), and increased hind limb utilization (P < 0.01). Supplementation of rhIGF-I therapy with a HPD resulted in a significant increase in muscle protein synthesis (P < 0.05) in addition to a further increase in the above parameters. We conclude that rhIGF-I causes an improvement in muscle metabolism, morphology, and function in dystrophic mice, and this effect is further enhanced by the presence of a HPD.

Original languageEnglish (US)
Pages (from-to)4880-4886
Number of pages7
Issue number11
StatePublished - Nov 1995
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology


Dive into the research topics of 'Effect of insulin-like growth factor i in murine muscular dystrophy'. Together they form a unique fingerprint.

Cite this